Glycoprotein 2b 3a inhibitor drugs

The mechanism of action of amiodarone is as a Cytochrome P450 3A Inhibitor, and P-Glycoprotein Inhibitor, and Cytochrome P450 1A2 Inhibitor, and Cytochrome P450

Amiodarone is an Antiarrhythmic. The mechanism of action of amiodarone is as a Cytochrome P450 3A Inhibitor, and P-Glycoprotein Inhibitor, and Cytochrome P450

fluoxetine, hydroxyzine, mibefradil, methadone, metoclopramide, moclobemide, Ritonavir/nirmatrelvir (Paxlovid) – inhibits P450 3A and p-glycoprotein causing.

by M Srinivasan 2024 Cited by 12Amiodarone inhibits cytochrome P450 (CYP) enzymes 3A and 2C and the drug transporter P-glycoprotein. This leads to impaired metabolism and

Drugs causing inadvertant photosensitivity Hypotensive Agents Imidazoles OAT1/SLC22A6 inhibitors P-glycoprotein inhibitors P-glycoprotein substrates

Coadministration of MAVYRET with drugs that inhibit hepatic P-gp, BCRP, or genotypes 1a, 1b, 2a, 2b, 3a, 4a, 5a, and 6a with IC50 values ranging from

The Most Important Antiplatelet Drugs COX-2 inhibitor / Cyclooxygenase inhibitors Phosphodiesterase inhibitors Glycoprotein IIB/IIIA

Amiodarone is an Antiarrhythmic. The mechanism of action of amiodarone is as a Cytochrome P450 3A Inhibitor, and P-Glycoprotein Inhibitor, and Cytochrome P450 1A2 Inhibitor, and Cytochrome P450 2C9 Inhibitor, and Cytochrome P450 2D6 Inhibitor.

fluoxetine, hydroxyzine, mibefradil, methadone, metoclopramide, moclobemide, Ritonavir/nirmatrelvir (Paxlovid) – inhibits P450 3A and p-glycoprotein causing.